Frank Torti - 29 Sep 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Frank Torti
Issuer symbol: IMVT
Transactions as of: 29 Sep 2022
Net transactions value: +$116,200
Form type: 4
Filing time: 29 Sep 2022, 16:21:03 UTC
Previous filing: 19 Aug 2022
Next filing: 14 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Purchase	$116,200	+20,000	+5.4%	$5.81	393,358	29 Sep 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.